SOSV

United States
SOSV is a global venture capital firm that operates early stage startup development programs. SOSV’s programs are focused on two broad areas. The first is revolutionary deep technology that promises the betterment of humanity and the planet. The second is cross-border markets, notably in Asia, that are ripe for explosive growth. The firm’s strategy is to invest in a small number of highly promising startups and use its deeply resourced programs to accelerate product development, acquire customers, and scale. SOSV companies consistently raise funding rounds led by top tier investors. SOSV joins seed, series A, and later rounds while providing founders with ongoing support and community.
Founded:1994
Firm Location:United States • Massachusetts • Connecticut • New York, New York • Los Angeles, California • San Francisco, California • Washington, District of Columbia • China • Shanghai • San Francisco Bay Area • New York City • Ireland • Lisbon, Portugal
Investor Firms That Co-Invest with SOSV
DFJAudrey CapitalHorizon PartnersO'Reilly AlphaTech VenturesStructure CapitalStaenberg Venture PartnersReal VenturesRareBreed VenturesGraph VenturesBloomberg BETACota CapitalRace CapitalNew Stack VenturesGoat CapitalPro Founders CapitalFifty YearsKapor CapitalAmad Capital VenturesExpon CapitalFuture VenturesChrysalix Venture CapitalCantos VenturesVayner RSEM34 CapitalConverge Venture PartnersMarket One Capital7percent VenturesFinch CapitalDBL PartnersHigh-Tech GründerfondsTectonic CapitalVirgin GroupHeavybitff Venture CapitalCraft VenturesScrum VenturesBaseline VenturesStray Dog CapitalAt One VenturesSVG Ventures-THRIVEAscend Venture CapitalVMG PartnersWestcott LLCBlockchain Founders FundSocial Impact CapitalTechstart VenturesTuesday CapitalIST cubeGGV CapitalAnorak VenturesBlue Bear VenturesValar VenturesBand of AngelsBonfire VenturesRefactor CapitalWasabi VenturesQualcomm VenturesFTW VenturesFoundry GroupTrinity VenturesAMASIAMerus CapitalBDC Venture CapitalBayern KapitalPrime VenturesTheVentureCityFPV FundAndreessen HorowitzKhosla VenturesInfinita FundiNovia CapitalFounders FundLightspeed Venture PartnersGolden VenturesCreative VenturesNextView VenturesSpringTime Ventures1517 FundXYZ Venture CapitalNeu Venture CapitalKompas VCRadical VenturesStarbridge Venture CapitalNew Enterprise Associates (NEA)DCMBuckley VenturesTwo Small Fish VenturesQ6 CapitalXTX VenturesCathay InnovationGradient VenturesTSVC CapitalKleiner PerkinsMayfieldOurCrowdTrue VenturesUncork CapitalAdvisors Fund LLCAlmaz CapitalAtypical VenturesSoffinova PartnersBroadview VenturesAudacityTrust VenturesWebtalk LtdRage CapitalUP.PartnersRiSo CapitalLateral Capital040 CapitalWill VenturesLateral FrontiersCurious CapitalLeFondsMetaplanetTango.vcLOI VentureAmazon Alexa FundAlliance of AngelsAirTree Ventures500 GlobalOutsized VenturesAscend Vietnam VenturesActive Impact InvestmentsUnchained Capital, Inc.dlabAccion Venture LabUnion Square VenturesREMUS Capital15th Rock VenturesAtlantic BridgeAtomicoOrange Fund (Orange DAO)Goodwater CapitalExpert DojoTechstarsRoot VenturesPractical Venture CapitalOne Way VenturesHalogen VenturesBlackbird Ventures AustraliaPlug & Play VenturesWhite Star CapitalCorazon CapitalMetaProp VenturesMenlo VenturesAnthemis GroupSlow VenturesDNA CapitalUnconventional VenturesEnergy Revolution VenturesBrkfst ClubHelium-3 VenturesPresight CapitalMatrixLowercarbon CapitalLux Capital ManagementEnergy Impact PartnersThird SphereOperator VenturesPrithvi VenturesEndeavor8The EngineAlumni Ventures GroupGaingelsENIAC VenturesSusa VenturesDraper AssociatesStellar Capital
SOSV Team
Photo of Michael Aberman, Partner at SOSV
Michael Aberman
SOSV·Partner
Sweet spot: $1M
Range: $100K - $2.0M
Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists)
Photo of Lindsay Atkenson, Analyst at SOSV
Lindsay Atkenson
SOSV·Analyst
Sweet spot: $1M
Range: $100K - $2.0M
Investors in Beijing, Investors in San Francisco (CA), Investors in New York (NY)
Investors in Semiconductors (Series B), Investors in Semiconductors (Pre-seed), Investors in Semiconductors (Pre-seed), Investors in Semiconductors (Series A), Investors in Semiconductors (Seed), Investors in Semiconductors (Series B), Investors in Enterprise Applications (Pre-seed), Investors in Semiconductors (Pre-seed), Investors in Semiconductors (Series A), Investors in Semiconductors (Seed), Investors in Semiconductors (Series B), Investors in BioTech (Series B), Investors in Enterprise Applications (Pre-seed), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Series A), Investors in BioTech (Pre-seed), Investors in Enterprise Applications (Seed), Investors in Semiconductors (Series A), Investors in Semiconductors (Seed), Investors in Enterprise Applications (Series B), Investors in BioTech (Series A), Investors in Enterprise Applications (Series A), Investors in BioTech (Pre-seed), Investors in Enterprise Applications (Seed), Investors in BioTech (Seed), Investors in Enterprise Applications (Pre-seed), Investors in BioTech (Series B), Investors in Consumer Internet (Pre-seed), Investors in Consumer Internet (Series B), Investors in Enterprise Applications (Series B), Investors in FinTech (Series B), Investors in Consumer Internet (Pre-seed), Investors in FinTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in FinTech (Pre-seed), Investors in BioTech (Series A), Investors in Enterprise Applications (Series A), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in FinTech (Series A), Investors in FinTech (Series B), Investors in Consumer Internet (Series A), Investors in Enterprise Applications (Seed), Investors in Consumer Internet (Seed), Investors in Consumer Internet (Series B), Investors in FinTech (Seed), Investors in Consumer Internet (Pre-seed), Investors in FinTech (Series A), Investors in BioTech (Series A), Investors in Consumer Internet (Series A), Investors in FinTech (Seed), Investors in Consumer Internet (Series B), Investors in BioTech (Seed), Investors in Consumer Internet (Seed), Investors in FinTech (Pre-seed), Investors in FinTech (Series B), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of William Bao Bean, General Partner at SOSV
William Bao Bean
SOSV·General Partner
Sweet spot: $1M
Range: $100K - $2.0M
Investors in Shanghai
Photo of Shawn Broderick, Venture Partner at SOSV
Shawn Broderick
SOSV·Venture Partner
Sweet spot: $500K
Range: $250K - $5.0M
Investors in Boston (MA)
Photo of Po Bronson, General Partner at SOSV
Po Bronson
SOSV·General Partner
Sweet spot: $500K
Range: $250K - $5.0M
Investors in San Francisco (CA)
Photo of Stephen Chambers, General Partner at SOSV
Stephen Chambers
SOSV·General Partner
Sweet spot: $1M
Range: $100K - $2.0M
Investors in London, Investors in New York (NY)
Photo of Cyril Ebersweiler, General Partner at SOSV
Cyril Ebersweiler
SOSV·General Partner
Sweet spot: $500K
Range: $250K - $5.0M
Investors in San Francisco (CA)
Investors in Hardware (Series A), Investors in Space (Series A), Investors in Space (Series A), Investors in Hardware (Seed), Investors in Robotics (Series A), Investors in Hardware (Series A), Investors in Space (Seed), Investors in Robotics (Series A), Investors in Space (Seed), Investors in Hardware (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Robotics (Seed), Investors in Digital Health (Seed), Investors in Robotics (Seed), Investors in Digital Health (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists)
Photo of Daniel Eichner, Partner at SOSV
Daniel Eichner
SOSV·Partner
Sweet spot: $1M
Range: $100K - $2.0M
Investors in New York City
Investors in MarketingTech (Series A), Investors in MarketingTech (Seed), Investors in MarketingTech (Series A), Investors in MarketingTech (Seed), Investors in FinTech (Series A), Investors in Enterprise (Series A), Investors in FinTech (Seed), Investors in Enterprise (Seed), Investors in FinTech (Series A), Investors in Enterprise (Series A), Investors in FinTech (Seed), Investors in Enterprise (Seed), Investors in New York City (Other Lists)
Photo of Hiruy Ephrem, Analyst at SOSV
Hiruy Ephrem
SOSV·Analyst
Sweet spot: $1M
Range: $100K - $2.0M
Investors in China
Investors in DeepTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed)
Photo of Weichang Ge, Analyst at SOSV
Weichang Ge
SOSV·Analyst
Sweet spot: $1M
Range: $100K - $2.0M
Investors in San Francisco (CA)
Photo of Sheng Ge, Partner at SOSV
Sheng Ge
SOSV·Partner
Sweet spot: $1M
Range: $100K - $2.0M
Investors in New York City, Investors in New York (NY)
Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Seed), Investors in DeepTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in DeepTech (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in New York City (Other Lists)
Photo of TR Harrington, Partner at SOSV
TR Harrington
SOSV·Partner
Sweet spot: $1M
Range: $100K - $2.0M
Investors in Egypt, Investors in Nigeria, Investors in Pakistan, Investors in Singapore, Investors in United States, Investors in Thailand, Investors in China, Investors in Indonesia, Investors in India
Photo of Bradford Higgins, Venture Partner at SOSV
Bradford Higgins
SOSV·Venture Partner
Sweet spot: $1M
Range: $100K - $2.0M
Investors in United States, Investors in New York (NY), Investors in Connecticut
Photo of Benjamin Joffe, Partner at SOSV
Benjamin Joffe
SOSV·Partner
Sweet spot: $500K
Range: $250K - $5.0M
Investors in Lisbon (Portugal), Investors in France, Investors in Paris (France)
Photo of Alex Kopelyan, Partner at SOSV
Alex Kopelyan
SOSV·Partner
Sweet spot: $250K
Range: $250K - $250K
Investors in United States, Investors in San Francisco (CA), Investors in SF Bay Area (CA)
Photo of Bill Liao, General Partner at SOSV
Bill Liao
SOSV·General Partner
Sweet spot: $200K
Range: $5K - $10.0M
Investors in United States
Photo of Yuan-Ting Meng, Analyst at SOSV
Yuan-Ting Meng
SOSV·Analyst
Sweet spot: $1M
Range: $100K - $2.0M
Investors in Global, Investors in Washington (DC)
Photo of Sean O'Sullivan, Managing Partner at SOSV
Sean O'Sullivan
SOSV·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Princeton (NJ)
Investors in Hardware (Pre-seed), Investors in Hardware (Series A), Investors in Hardware (Seed), Investors in BioTech (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Marketplaces (Pre-seed), Investors in ClimateTech/CleanTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in Marketplaces (Series A), Investors in Marketplaces (Seed), Investors in New York City (Other Lists)
Photo of Oscar Ramos, General Partner at SOSV
Oscar Ramos
SOSV·General Partner
Sweet spot: $180K
Range: $150K - $180K
Investors in Earth
Photo of Parikshit Sharma, Principal at SOSV
Parikshit Sharma
SOSV·Principal
Sweet spot: $250K
Range: $250K - $500K
Investors in SF Bay Area (CA), Investors in San Francisco (CA)
Investors in Medical Devices (Pre-seed), Investors in Material Science (Series A), Investors in Medical Devices (Pre-seed), Investors in Material Science (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in Material Science (Series A), Investors in Material Science (Series B), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Series B), Investors in Food and Beverage (Series A), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series B), Investors in AgTech (Series B), Investors in AgTech (Series B), Investors in Food and Beverage (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Material Science (Seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Seed), Investors in Impact (Pre-seed), Investors in Food and Beverage (Series B), Investors in Medical Devices (Series A), Investors in Food and Beverage (Series B), Investors in AgTech (Series A), Investors in Pharmaceuticals (Series B), Investors in EnergyTech (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in EnergyTech (Series B), Investors in Impact (Pre-seed), Investors in Impact (Series B), Investors in EnergyTech (Series B), Investors in AgTech (Pre-seed), Investors in AgTech (Series A), Investors in Impact (Series A), Investors in Food and Beverage (Series A), Investors in AgTech (Pre-seed), Investors in Food and Beverage (Seed), Investors in Impact (Series B), Investors in EnergyTech (Series A), Investors in EnergyTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in Impact (Series A), Investors in EnergyTech (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Impact (Seed), Investors in EnergyTech (Seed), Investors in Consumer Health (Pre-seed), Investors in AgTech (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Food and Beverage (Seed), Investors in Impact (Seed), Investors in AgTech (Seed), Investors in Consumer Health (Pre-seed), Investors in Consumer Health (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Diverse Investors (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Mohan S. Iyer, General Partner at SOSV
Mohan S. Iyer
SOSV·General Partner
Sweet spot: $1M
Range: $100K - $2.0M
Investors in SF Bay Area (CA), Investors in San Francisco (CA)
Investors in Digital Health (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Pre-seed), Investors in Consumer Health (Series B), Investors in Consumer Health (Pre-seed), Investors in Health IT (Pre-seed), Investors in Consumer Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Consumer Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Pre-seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in San Francisco Bay Area (Other Lists)
Photo of Duncan Turner, General Partner at SOSV
Duncan Turner
SOSV·General Partner
Sweet spot: $1M
Range: $100K - $2.0M
Investors in New York City
Investors in Health & Hospital Services (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Manufacturing (Series B), Investors in Manufacturing (Series B), Investors in IoT (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Manufacturing (Seed), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in IoT (Series A), Investors in Digital Health (Pre-seed), Investors in Health IT (Series A), Investors in IoT (Seed), Investors in Health & Hospital Services (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Robotics (Pre-seed), Investors in IoT (Pre-seed), Investors in AI (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Manufacturing (Series A), Investors in Manufacturing (Pre-seed), Investors in AI (Series A), Investors in Consumer Health (Seed), Investors in Robotics (Seed), Investors in Consumer Health (Pre-seed), Investors in Digital Health (Seed), Investors in Robotics (Series A), Investors in Health IT (Pre-seed), Investors in Manufacturing (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Series A), Investors in Digital Health (Pre-seed), Investors in ClimateTech/CleanTech (Series B), Investors in AI (Pre-seed), Investors in Robotics (Series B), Investors in AI (Seed), Investors in IoT (Pre-seed), Investors in Robotics (Pre-seed), Investors in Enterprise (Series B), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Pre-seed), Investors in ClimateTech/CleanTech (Series A), Investors in Consumer Health (Pre-seed), Investors in Digital Health (Series B), Investors in Enterprise (Pre-seed), Investors in Robotics (Series B), Investors in ClimateTech/CleanTech (Seed), Investors in Enterprise (Series A), Investors in AI (Series B), Investors in Digital Health (Seed), Investors in IoT (Series B), Investors in Robotics (Series A), Investors in Health IT (Pre-seed), Investors in Consumer Health (Series B), Investors in IoT (Series A), Investors in IoT (Seed), Investors in Enterprise (Seed), Investors in Robotics (Seed), Investors in AI (Pre-seed), Investors in Consumer Health (Series A), Investors in AI (Series A), Investors in Consumer Health (Seed), Investors in Health IT (Series B), Investors in AI (Seed), Investors in Enterprise (Pre-seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Enterprise (Series B), Investors in Enterprise (Seed), Investors in Enterprise (Series A), Investors in New York City (Other Lists)
Photo of Pae Wu, General Partner at SOSV
Pae Wu
SOSV·General Partner
Sweet spot: $1M
Range: $100K - $2.0M
Investors in United States